Literature DB >> 8968543

Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.

R E de Boer1, M R Steegstra, P A Kroezen, J Smit, J Zaagsma.   

Abstract

1. In oesophageal smooth muscle strips from spontaneously hypertensive rats (SHR) of 8-10 and 22-24 weeks of age, respectively, beta-adrenoceptor-mediated relaxation was investigated, by use of the beta-agonists, (-)-isoprenaline and fenoterol (both in the absence and presence of the beta 2-selective antagonist ICI 118,551) and the selective beta 3-agonist, BRL 37,344. 2. In preparations from 8-10 week SHR, (-)-isoprenaline- and fenoterol-induced concentration-response curves (CRCs) were hardly antagonized by ICI 118,551 at concentrations up to 1 microM, indicating only a minor contribution of beta 2-adrenoceptors. pA2-values for ICI 118,551 of 5.30 ((-)-isoprenaline as agonist) and 5.46 (fenoterol as agonist), estimated from the shifts at the highest (10-100 microM) antagonist concentrations, are consistent with affinity at a beta 3-adrenoceptor, similar to that in Wistar rat oesophageal smooth muscle. 3. In 8-10 week SHR, adrenodemedullated at 4 weeks of age (SHR-ADM4) the potency of fenoterol was markedly increased and CRCs were shallow. In addition, ICI 118,551 (0.1 microM) now produced a clear rightward shift accompanied by a steepening of the CRC. A marked further shift was observed only at 100 microM of the antagonist. The data are compatible with the involvement of both beta 2- and beta 3-adrenoceptors. 4. In 22-24 week animals, the same differences between SHR and SHR-ADM4 were observed with fenoterol as in 8-10 week animals, though beta-adrenoceptor responsiveness was slightly decreased. The potency of ICI 118,551 at beta 3-adrenoceptors (pA2 = 5.11) was significantly different from the pA2 value of 5.46 obtained with the younger animals. 5. Responses to the beta 3-adrenoceptor agonist, BRL 37,344, were similar in Wistar rat and SHR preparations. In 8-10 week SHR, a small decrease in the maximal response was observed, which in animals of 22-24 weeks of age was accompanied by a small decrease in the pEC50 value as well. 6. The results clearly indicate that beta 2-adrenoceptors in SHR oesophageal muscularis mucosae are desensitized, whereas beta 3-adrenoceptor-mediated responses are unaffected and similar to the responses observed in the Wistar rat oesophagus. The functional presence of beta 2-adrenoceptor-responses in SHR-ADM4 suggests a major role for adrenal-derived adrenaline in the desensitization of the beta 2-adrenoceptor-population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968543      PMCID: PMC1915822          DOI: 10.1111/j.1476-5381.1996.tb16046.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

Review 1.  Vascular reactivity in systemic arterial hypertension.

Authors:  M Mendlowitz
Journal:  Am Heart J       Date:  1973-02       Impact factor: 4.749

2.  The beta-adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3-, but also of the beta 2-subtype.

Authors:  R E de Boer; F Brouwer; J Zaagsma
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Vascular beta-adrenoceptor-mediated responses in hypertension and ageing in rats.

Authors:  K R Borkowski; R Gros; H Schneider
Journal:  J Auton Pharmacol       Date:  1992-12

4.  Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. I. Renal alpha 1-, alpha 2-, and beta-adrenergic receptors and their signaling.

Authors:  M C Michel; F Siepmann; R Büscher; T Philipp; O E Brodde
Journal:  Hypertension       Date:  1993-08       Impact factor: 10.190

5.  Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.

Authors:  C Carpéné; J Galitzky; P Collon; F Esclapez; M Dauzats; M Lafontan
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

6.  Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements.

Authors:  R F Thomas; B D Holt; D A Schwinn; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.

Authors:  S B Liggett; N J Freedman; D A Schwinn; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.

Authors:  F Nantel; H Bonin; L J Emorine; V Zilberfarb; A D Strosberg; M Bouvier; S Marullo
Journal:  Mol Pharmacol       Date:  1993-04       Impact factor: 4.436

9.  Differential adrenergic regulation of beta 1- and beta 3-adrenoreceptor messenger ribonucleic acids in adipose tissues.

Authors:  J G Granneman; K N Lahners
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  Dysfunctional presynaptic alpha 2-adrenoceptors expose facilitatory beta 2-adrenoceptors in the vasculature of spontaneously hypertensive rats.

Authors:  R Remie; J X Van Rossum; R P Coppes; J Zaagsma
Journal:  Eur J Pharmacol       Date:  1992-02-11       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.